NRP1 and non-small cell lung carcinoma: EGFR serves as a transmembrane receptor primarily situated on the cell surface and is frequently overexpressed in patients with non-small cell lung cancer (NSCLC), thereby facilitating tumor cell proliferation and metastasis [15, 16].